Gene Expression Profiling In Lymphoma Diagnosis and Research

Chan, Wing C.
June 2005
Croatian Medical Journal;2005, Vol. 46 Issue 3, p349
Academic Journal
Gene expression profiling in the past 5 years has generated a large amount of data on a variety of malignancies. Unique gene expression signatures have been identified for the more common types of non-Hodgkin lymphoma (NHL), including clinically and biologically important subsets that have not been defined before. In addition, molecularly defined prognosticators have also been constructed for the major types of NHL and these prognosticators provide added value to the widely used International Prognostic Index. The new information should be included in our evaluation of NHL patients, especially when conducting clinical trials. Studies are ongoing to validate and refine these diagnostic and prognostic signatures and to develop platforms that are suitable for routine clinical applications. Similar studies will be performed on the less common types of NHL to complete the molecular classification of NHLs. It is also anticipated that gene expression profiling studies will lead to the identification of novel targets for the development of new therapeutic agents for NHL.


Related Articles

  • Significance of Bcl-2 and Bcl-6 immunostaining in B-Non Hodgkin's lymphoma. Mahmoud, Hanan Mohamed; El-Sakhawy, Yasmin Nabil // Hematology Reviews;2011, Vol. 3 Issue 3, p80 

    The determination of prognosis for B-Non-Hodgkin's lymphoma (NHL) is known to be related to the multiple differences in tumor cell biology. Bcl-2 and Bcl-6 are two markers linked to germinal center B cells. Both markers are thought to have an effect on prognosis of mature B-cell neoplasms....

  • Expression pattern of intracellular leukocyte-associated proteins in primary mediastinal B cell lymphoma. Marafioti, T.; Pozzobon, M.; Hansmann, M.-L.; Gaulard, P.; Barth, T. F.; Copie-Bergman, C.; Roberton, H.; Ventura, R.; Martín-Subero, J. I.; Gascoyne, R. D.; Pileri, S. A.; Siebert, R.; Hsi, E. D.; Natkunam, Y.; Möller, P.; Mason, D. Y.; Martín-Subero, J I; Möller, P // Leukemia (08876924);May2005, Vol. 19 Issue 5, p856 

    Two microarray studies of mediastinal B cell lymphoma have shown that this disease has a distinct gene expression profile, and also that this is closest to the pattern seen in classical Hodgkin's disease. We reported previously an immunohistologic study in which the loss of intracellular B...

  • High expression of several tyrosine kinases and activation of the PI3K/AKT pathway in mediastinal large B cell lymphoma reveals further similarities to Hodgkin lymphoma. Renné, C.; Willenbrock, K.; Martin-Subero, J. I.; Hinsch, N.; Döring, C.; Tiacci, E.; Klapper, W.; Möller, P.; Küppers, R.; Hansmann, M. L.; Siebert, R.; Bräuninger, A. // Leukemia (08876924);Apr2007, Vol. 21 Issue 4, p780 

    Mediastinal large B-cell (MBL) and classical Hodgkin lymphoma (HL) have several pathogenic mechanisms in common. As we recently observed aberrant tyrosine kinase (TK) activities in HL, we now analysed also MBL for such activities. Indeed, MBL and HL were the only B-cell lymphomas where elevated...

  • Immunohistochemical and Molecular Characteristics with Prognostic Significance in Diffuse Large B-Cell Lymphoma. Bellas, Carmen; García, Diego; Vicente, Yolanda; Kilany, Linah; Abraira, Victor; Navarro, Belen; Provencio, Mariano; Martín, Paloma // PLoS ONE;Jun2014, Vol. 9 Issue 6, p1 

    Diffuse large B-cell lymphoma (DLBCL) is an aggressive non-Hodgkin lymphoma with marked biologic heterogeneity. We analyzed 100 cases of DLBCL to evaluate the prognostic value of immunohistochemical markers derived from the gene expression profiling-defined cell origin signature, including MYC,...

  • An Immunophenotypic and Molecular Study of Primary Large B-Cell Lymphoma of Bone. Huebner-Chan, David; Fernandes, Bernie; Yang, Guisheng; Lim, Megan S. // Modern Pathology;Oct2001, Vol. 14 Issue 10, p1000 

    Primary non-Hodgkin’s lymphomas of bone (PNHLB) is a rare form of extranodal lymphoma. Many studies have reported the clinical, radiologic, and histopathologic characteristics of PNHLB; however, their molecular features have not been well studied. In this report, we present the...

  • Inhibition of miR-9 de-represses HuR and DICER1 and impairs Hodgkin lymphoma tumour outgrowth in vivo. Leucci, E; Zriwil, A; Gregersen, L H; Jensen, K T; Obad, S; Bellan, C; Leoncini, L; Kauppinen, S; Lund, A H // Oncogene;12/6/2012, Vol. 31 Issue 49, p5081 

    MicroRNAs are important regulators of gene expression in normal development and disease. miR-9 is overexpressed in several cancer forms, including brain tumours, hepatocellular carcinomas, breast cancer and Hodgkin lymphoma (HL). Here we demonstrated a relevance for miR-9 in HL pathogenesis and...

  • Constitutive overexpression of a novel 21 kDa protein by Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphomas. Minglong Zhou; Fadlelmola, Faisal M.; Cohn, Jason B.; Skinnider, Brian; Gascoyne, Randy D.; Banerjee, Diponkar // Molecular Cancer;2008, Vol. 7, Special section p1 

    Background: CD30, a 120 kDa surface phosphorylated protein is a member of tumour necrosis/ nerve growth factor receptor (TNF/NGFR) family and constitutively expressed by Hodgkin and Reed-Sternberg (HRS) cells of Hodgkin lymphoma (HL) and the neoplastic cells of Anaplastic Large Cell Lymphoma...

  • Non-Hodgkin's lymphoma presenting as a primary bladder tumor: a case report. Díaz-Peromingo, José A.; Tato-Rodríguez, Javier; Pesqueira-Fontán, Paula M.; Molinos-Castro, Sonia; Fernández, María C. Gayol-; Struzik, Juliusz P. // Journal of Medical Case Reports;2010, Vol. 4 Issue 1, p1 

    Introduction: Primary lymphoma of the bladder represents 0.2% of all bladder malignancies. Secondary involvement of the bladder by malignant lymphoma occurs in 10% to 50% of cases. Most lymphomas of the bladder are non- Hodgkin's lymphomas of the B-cell type, with preponderance among women. The...

  • Genetics and diffuse large B-Cell lymphoma. NIROULA, RABIN; BUTERA, JAMES // Rhode Island Medical Journal;Nov2015, Vol. 98 Issue 11, p23 

    Diffuse large B-Cell lymphoma (DLBCL) is one of the most common and aggressive subtypes of non-Hodgkin's lymphoma (NHL). Gene expression profiling (GEP) studies have identified at least two distinct molecular subtypes of DLBCL termed as germinal center B-cell (GCB) and activated B-cell (ABC)....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics